The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Adverse side effects of recently approved Alzheimer’s therapy, lecanemab, are ‘manageable', reported a new study published in JAMA Neurology. The findings may inform discussions about the risks of ...

A new study finds that taking arginine orally may lower amyloid buildup and neuroinflammation, suggesting a safe, low-cost ...

Alzheimer’s, the leading cause of dementia, affects some six million individuals nationwide, and 55 million worldwide. The disease, projected to impact 139 million people globally by 2050, can impair ...

Eli Lilly's Alzheimer's treatment is approved for use in the U.S. but the European Medicines Agency recommended against the approval of the drug on Thursday. Indiana-based pharmaceutical company Eli ...

Alzheimer’s patients in the European Union will have to keep waiting for new treatments after regulators blocked a drug that’s already been approved in the United States and the United Kingdom. The ...

A FAT jab could help slow down Alzheimer’s by slashing brain shrinkage, according to a small British study. Liraglutide, the ...

It is estimated that 46.8 million people worldwide are living with dementia, with Alzheimer's disease the most common form. Now researchers from the University of Southampton have discovered a ...

Researchers at Karolinska Institutet in Sweden and the RIKEN Center for Brain Science in Japan have identified two receptors ...

Althea Jordan sits in her white recliner while her physical therapist, Danielle Heltzel, kneels on the floor in front of her to go through a series of exercises to help move her legs. “Did I ask if ...

To learn more about the drug’s serious side effects, talk with your doctor or see donepezil’s prescribing information. The side effects of donepezil are generally the same regardless of age. But ...